Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP3 | P08254 | 12/20 | 0.44 |
| ▸ | MMP2 | P08253 | 12/20 | 0.44 |
| ▸ | MMP1 | P03956 | 10/20 | 0.44 |
| ▸ | MMP9 | P14780 | 5/20 | 0.44 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.44 |
| ▸ | MMP13 | P45452 | 2/20 | 0.44 |
| ▸ | MMP8 | P22894 | 1/20 | 0.44 |
| ▸ | MMP14 | P50281 | 1/20 | 0.44 |
| ▸ | MMP7 | P09237 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7372625 | 0.91 | MMP2 (0.51) | MMP3MMP2MMP1MMP9ADAM17 | |
| SCHEMBL7368610 | 0.89 | ANPEP (0.43) | MMP3MMP2MMP1MMP9ADAM17 | |
| SCHEMBL7406850 | 0.89 | MMP2 (0.50) | MMP3MMP2MMP1MMP9ADAM17 | |
| SCHEMBL7372936 | 0.84 | ADAM17 (0.43) | MMP3MMP2MMP1MMP9ADAM17 | |
| SCHEMBL7372142 | 0.82 | MMP3 (0.43) | MMP3MMP2MMP1MMP9ADAM17 | |
| SCHEMBL8777469 | 0.82 | MMP1 (0.49) | MMP3MMP2MMP1MMP9ADAM17 | |
| SCHEMBL7411762 | 0.81 | MMP1 (0.58) | MMP3MMP2MMP1MMP9ADAM17 | |
| SCHEMBL7371930 | 0.79 | HSPA5 (0.48) | MMP3MMP2MMP1MMP9ADAM17 | |
| SCHEMBL8189738 | 0.78 | MMP1 (0.47) | MMP3MMP2MMP1MMP9ADAM17 | |
| SCHEMBL8777482 | 0.76 | MMP3 (0.44) | MMP3MMP2MMP1MMP9ADAM17 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0740652-B1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARM (GB) | 1998-05-06 | — | — | EP | claimed |
| EP-0740652-A1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1996-11-06 | — | — | EP | claimed |
| WO-1995019956-A1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1995-07-27 | — | — | WO | claimed |
| US-5919940-A | TERT-LEUCINE-THIAZOL-2-YLAMIDE | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1999-07-06 | — | — | US | disclosed |
| US-5859253-A | L-TERT-LEUCINE-2-PYRIDYLAMIDE | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1999-01-12 | — | — | US | disclosed |
| EP-0740652-B1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARM (GB) | 1998-05-06 | — | — | EP | disclosed |
| US-5747514-A | Metalloproteinase inhibitors | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1998-05-05 | — | — | US | disclosed |
| EP-0740652-A1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1996-11-06 | — | — | EP | disclosed |
| WO-1995019956-A1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1995-07-27 | — | — | WO | disclosed |